Published in Mol Med on August 01, 1999
Basic local alignment search tool. J Mol Biol (1990) 659.07
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75
Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science (1992) 24.32
CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res (1987) 15.65
Gene expression profiles in normal and cancer cells. Science (1997) 9.65
c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell (1988) 6.24
Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science (1994) 5.37
Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res (1982) 5.14
Transformation of rat cells by DNA of human adenovirus 5. Virology (1973) 4.85
Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc Natl Acad Sci U S A (1989) 4.81
Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. Nature (1991) 4.17
Activation of the c-fos gene by UV and phorbol ester: different signal transduction pathways converge to the same enhancer element. Oncogene (1988) 2.43
Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc Natl Acad Sci U S A (1994) 2.43
Conserved motifs in Fos and Jun define a new class of activation domain. Genes Dev (1992) 1.90
Identification by differential display of alpha 6 integrin as a candidate tumor suppressor gene. FASEB J (1993) 1.83
Modulation of c-fos gene transcription by negative and positive cellular factors. Nature (1987) 1.83
Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res (1990) 1.80
Expression genetics in cancer: shifting the focus from DNA to RNA. Proc Natl Acad Sci U S A (1997) 1.69
Isolation, characterization, and UV-stimulated expression of two families of genes encoding polypeptides of related structure in human epidermal keratinocytes. Mol Cell Biol (1988) 1.52
An NF-kappa B-like transcription factor mediates IL-1/TNF-alpha induction of gro in human fibroblasts. J Immunol (1991) 1.42
Activation of mammalian gene expression by the UV component of sunlight--from models to reality. Bioessays (1996) 1.39
Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response. Cancer Res (1997) 1.36
Molecular characterization and evolution of the SPRR family of keratinocyte differentiation markers encoding small proline-rich proteins. Genomics (1993) 1.30
RNA genetics of breast cancer: maspin as paradigm. Cold Spring Harb Symp Quant Biol (1994) 1.26
A novel protease homolog differentially expressed in breast and ovarian cancer. Mol Med (1996) 1.20
Identification, cloning, and characterization of cystatin M, a novel cysteine proteinase inhibitor, down-regulated in breast cancer. J Biol Chem (1997) 1.19
Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin. Cell Growth Differ (1997) 1.19
Novel protein in human epidermal keratinocytes: regulation of expression during differentiation. Mol Cell Biol (1988) 1.09
Induction of oncogenic transformation in vitro by ultraviolet light. Nature (1976) 1.09
Growth-responsive expression from the murine thymidine kinase promoter: genetic analysis of DNA sequences. Cell Growth Differ (1991) 1.03
Constitutive AP-1 DNA binding and transactivating ability of malignant but not benign mouse epidermal cells. Mol Carcinog (1994) 0.92
Characterization of the human spr2 promoter: induction after UV irradiation or TPA treatment and regulation during differentiation of cultured primary keratinocytes. Nucleic Acids Res (1990) 0.89
Isolation and characterization of the human spr1 gene and its regulation of expression by phorbol ester and cyclic AMP. J Biol Chem (1993) 0.87
Expression genetics: a different approach to cancer diagnosis and prognosis. Trends Biotechnol (1998) 0.84
Re-expression of elafin in 21MT2 breast carcinomas by phorbol 12-myristate 13-acetate is mediated by the Ap1 site in the elafin promoter. Cancer Res (1997) 0.83
Expression of human squamous cell differentiation marker, SPR1, in tracheobronchial epithelium depends on JUN and TRE motifs. J Biol Chem (1995) 0.82
Two nuclear proteins in tracheal epithelial cells are recognized by antibodies specific to a squamous differentiation marker, sprI. J Cell Physiol (1995) 0.81
Expression of the spr1 gene in cultured tracheal epithelial cells and its regulation by retinoids before and after confluence. J Cell Physiol (1996) 0.77
Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science (1994) 5.37
Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc Natl Acad Sci U S A (1989) 4.81
Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells. Proc Natl Acad Sci U S A (1987) 3.74
Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc Natl Acad Sci U S A (1990) 3.40
Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res (1992) 3.12
Selective silencing of eukaryotic DNA. Science (1975) 2.90
Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc Natl Acad Sci U S A (1991) 2.43
Oxygen and Light Induced Oxidations of Cytochrome, Flavoprotein, and Pyridine Nucleotide in a Chlamydomonas Mutant. Plant Physiol (1957) 2.28
Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci U S A (1996) 2.20
Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells. J Virol (1991) 2.14
Molecular basis of maternal inheritance. Proc Natl Acad Sci U S A (1972) 2.11
Functional diversity of gro gene expression in human fibroblasts and mammary epithelial cells. Proc Natl Acad Sci U S A (1988) 2.07
Biparental inheritance of nonchromosomal genes induced by ultraviolet irradiation. Proc Natl Acad Sci U S A (1967) 2.00
Genomic rearrangements in a mouse cell line containing integrated SV40 DNA. Cell (1981) 1.94
Identification of three related human GRO genes encoding cytokine functions. Proc Natl Acad Sci U S A (1990) 1.86
Identification by differential display of alpha 6 integrin as a candidate tumor suppressor gene. FASEB J (1993) 1.83
Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells. Proc Natl Acad Sci U S A (1990) 1.81
Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res (1990) 1.80
Resistance of human cells to tumorigenesis induced by cloned transforming genes. Proc Natl Acad Sci U S A (1983) 1.79
Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol (1996) 1.79
Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ (1996) 1.73
Regulation of the Chlamydomonas cell cycle by light and dark. J Cell Biol (1980) 1.73
A genetic map of non-Mandelian genes in Chlamydomonas. Proc Natl Acad Sci U S A (1970) 1.72
Suppression of tumor growth by senescence in virally transformed human fibroblasts. Proc Natl Acad Sci U S A (1986) 1.70
Recombination of nonchromosomal genes in Chlamydomonas. Proc Natl Acad Sci U S A (1965) 1.65
Genetic analysis of tumorigenesis: I. Expression of tumor-forming ability in hamster hybrid cell lines. Somatic Cell Genet (1978) 1.60
Role of methylation in the modification and restriction of chloroplast DNA in Chlamydomonas. Proc Natl Acad Sci U S A (1979) 1.55
Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cells. Cancer Res (1988) 1.52
Denaturation and the renaturation kinetics of chloroplast DNA from Chlamydomonas reinhardi. J Mol Biol (1971) 1.46
Chloroplast Genetics of Chlamydomonas. III. Closing the Circle. Genetics (1976) 1.46
Mutations that alter the transmission of chloroplast genes in Chlamydomonas. Proc Natl Acad Sci U S A (1974) 1.42
Pre-adipocyte determination either by insulin or by 5-azacytidine. Proc Natl Acad Sci U S A (1982) 1.42
An NF-kappa B-like transcription factor mediates IL-1/TNF-alpha induction of gro in human fibroblasts. J Immunol (1991) 1.42
Azacytidine-induced tumorigenesis of CHEF/18 cells: correlated DNA methylation and chromosome changes. Proc Natl Acad Sci U S A (1983) 1.41
Linking gene expression patterns to therapeutic groups in breast cancer. Cancer Res (2000) 1.40
Production, purification, and characterization of recombinant maspin proteins. J Biol Chem (1994) 1.38
Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines. J Cell Biol (1992) 1.36
Genetic analysis of chloroplast DNA in Chlamydomonas. Adv Genet (1977) 1.36
Localization of five antibiotic resistances at the subunit level in chloroplast ribosomes of Chlamydomonas. Proc Natl Acad Sci U S A (1974) 1.35
Methylation of chloroplast DNAs in the life cycle of Chlamydomonas. Proc Natl Acad Sci U S A (1979) 1.34
Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment. Proc Natl Acad Sci U S A (1992) 1.34
maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res (1998) 1.32
Tissue specificity and clustering of methylated cystosines in bovine satellite I DNA. Proc Natl Acad Sci U S A (1982) 1.31
Suppression of tumorigenicity in hybrids of normal and oncogene-transformed CHEF cells. Proc Natl Acad Sci U S A (1985) 1.31
Cytoplasmic and chloroplast ribosomes of Chlamydomonas: ultracentrifugal characterization. Science (1967) 1.30
Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Cancer Res (1993) 1.27
RNA genetics of breast cancer: maspin as paradigm. Cold Spring Harb Symp Quant Biol (1994) 1.26
Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells. Proc Natl Acad Sci U S A (1990) 1.24
Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid. Proc Natl Acad Sci U S A (1995) 1.22
Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br J Pharmacol (1995) 1.22
The mat-1 gene in Chlamydomonas regulates DNA methylation during gametogenesis. Cell (1981) 1.21
The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin. Cancer Res (2000) 1.21
A novel protease homolog differentially expressed in breast and ovarian cancer. Mol Med (1996) 1.20
Expression of maspin in prostate cells is regulated by a positive ets element and a negative hormonal responsive element site recognized by androgen receptor. Proc Natl Acad Sci U S A (1997) 1.20
Genetic suppression of tumor formation: a new frontier in cancer research. Cancer Res (1986) 1.19
Identification, cloning, and characterization of cystatin M, a novel cysteine proteinase inhibitor, down-regulated in breast cancer. J Biol Chem (1997) 1.19
Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin. Cell Growth Differ (1997) 1.19
Down-regulation of a calmodulin-related gene during transformation of human mammary epithelial cells. Proc Natl Acad Sci U S A (1990) 1.19
Gene amplification: an example of accelerated evolution in tumorigenic cells. Proc Natl Acad Sci U S A (1985) 1.19
The tumor suppressor maspin does not undergo the stressed to relaxed transition or inhibit trypsin-like serine proteases. Evidence that maspin is not a protease inhibitory serpin. J Biol Chem (1995) 1.18
Down-regulation of retinoic acid receptor beta in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Differ (1994) 1.17
Specificity of gap junction communication among human mammary cells and connexin transfectants in culture. J Cell Biol (1993) 1.14
Differential activity of DNA methyltransferase in the life cycle of Chlamydomonas reinhardi. Proc Natl Acad Sci U S A (1981) 1.14
A newly established metastatic breast tumor cell line with integrated amplified copies of ERBB2 and double minute chromosomes. Genes Chromosomes Cancer (1989) 1.14
Mutation of a cytoplasmic gene in Chlamydomonas alters chlorplast ribosome function. Proc Natl Acad Sci U S A (1972) 1.13
A cautionary note on reaction tubes for differential display and cDNA amplification in thermal cycling. Biotechniques (1994) 1.13
The human papilloma virus 16E6 gene sensitizes human mammary epithelial cells to apoptosis induced by DNA damage. Proc Natl Acad Sci U S A (1995) 1.12
Regulation of nuclear DNA replication by thechloroplast in Chlamydomonas. Proc Natl Acad Sci U S A (1974) 1.11
A site-specific single-strand endonuclease from the eukaryote Chlamydomonas. Proc Natl Acad Sci U S A (1977) 1.10
Leptin production and release in the dually in vitro perfused human placenta. J Clin Endocrinol Metab (2000) 1.09
Identification of 5-methylcytosine in DNA fragments immobilized on nitrocellulose paper. Proc Natl Acad Sci U S A (1980) 1.08
Down-regulation of laminin-5 in breast carcinoma cells. Mol Med (1998) 1.07
Maspin plays an important role in mammary gland development. Dev Biol (1999) 1.06
Tumorigenicity and its suppression in cybrids of mouse and Chinese hamster cell lines. Proc Natl Acad Sci U S A (1978) 1.06
Differential expression of elafin in human normal mammary epithelial cells and carcinomas is regulated at the transcriptional level. Cancer Res (1995) 1.05
Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications. Clin Biochem (2000) 1.05
Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin. Proc Natl Acad Sci U S A (1998) 1.04
Maternal-fetal transport of immunoglobulin G and its subclasses during the third trimester of human pregnancy. Am J Reprod Immunol (1994) 1.02
Transfection with plasmid pSV2gptEJ induces chromosome rearrangements in CHEF cells. Proc Natl Acad Sci U S A (1987) 1.01
Control of maternal inheritance by DNA methylation in chlamydomonas. Curr Top Microbiol Immunol (1984) 1.01
Cytoplasmic genetics of mammalian cells: conditional sensitivity to mitochondrial inhibitors and isolation of new mutant phenotypes. Somatic Cell Genet (1979) 1.00
Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice. Oncogene (2000) 0.97
Plasmid-induced "hit-and-run" tumorigenesis in Chinese hamster embryo fibroblast (CHEF) cells. Proc Natl Acad Sci U S A (1985) 0.97
Deoxyribonucleic acid methyltransferase from the eukaryote, Chlamydomonas reinhardi. Eur J Biochem (1980) 0.97
Cystatin M/E expression is restricted to differentiated epidermal keratinocytes and sweat glands: a new skin-specific proteinase inhibitor that is a target for cross-linking by transglutaminase. J Invest Dermatol (2001) 0.94
Multistep origin of tumor-forming ability in Chinese hamster embryo fibroblast cells. Cancer Res (1982) 0.93
Genetic analysis of tumorigenesis: VI. Chromosome rearrangements in tumors derived from diploid premalignant Chinese hamster cells in nude mice. Somatic Cell Genet (1980) 0.93
mMaspin: the mouse homolog of a human tumor suppressor gene inhibits mammary tumor invasion and motility. Mol Med (1997) 0.93
Genetic analysis of tumorigenesis: XVI. Chromosome changes in azacytidine- and insulin-induced tumorigenesis. Somat Cell Mol Genet (1984) 0.92
Protein composition of microparticles shed from human placenta during placental perfusion: Potential role in angiogenesis and fibrinolysis in preeclampsia. Placenta (2010) 0.92
Genetic analysis of tumorigenesis: X. Chromosome studies of transformed mutants and tumor-derived CHEF/18 cells. Somatic Cell Genet (1982) 0.92
Genetic suppression of tumor formation. Adv Cancer Res (1985) 0.91
Genomic rearrangements and tumor-forming potential in an SV40-transformed mouse cell line and its hybrid and cybrid progeny. Cold Spring Harb Symp Quant Biol (1981) 0.91
Ethidium bromide induced selective and reversible loss of chloroplast DNA. Nat New Biol (1973) 0.91
Genetic analysis of tumorigenesis: V. Chromosomal analysis of tumorigenic and nontumorigenic diploid chinese hamster cell lines. Somatic Cell Genet (1980) 0.91
Asymmetrical transport of glucose across the in vitro perfused human placenta. Placenta (2003) 0.90
Maspin--a novel protease inhibitor with tumor-suppressing activity in breast cancer. Acta Oncol (2000) 0.90
Cytokine dysregulation in AIDS: in vivo overexpression of mRNA of tumor necrosis factor-alpha and its correlation with that of the inflammatory cytokine GRO. J Acquir Immune Defic Syndr (1992) 0.89
Effect of hypoxia, oxidative stress and lipopolysaccharides on the release of prostaglandins and cytokines from human term placental explants. Placenta (2001) 0.89